Cargando…
Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin
In our case, a 45-year-old male patient had multiple fractures accompanied by hypophosphatemia. FGF-23 levels were significantly increased, and total body magnetic resonance imaging (MRI) revealed a tumor mass located at the distal tibia leading to the diagnosis of tumor-induced osteomalacia (TIO)....
Autores principales: | Hautmann, Anke H., Schroeder, Josef, Wild, Peter, Hautmann, Matthias G., Huber, Elisabeth, Hoffstetter, Patrick, Fleck, Martin, Girlich, Christiane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158256/ https://www.ncbi.nlm.nih.gov/pubmed/25221676 http://dx.doi.org/10.1155/2014/729387 |
Ejemplares similares
-
Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant
por: Shiba, Eisuke, et al.
Publicado: (2016) -
Tumor-induced osteomalacia caused by a phosphaturic mesenchymal tumor of the femur
por: Liu, Shu-Zhong, et al.
Publicado: (2019) -
Selective blood sampling for FGF-23 in tumor-induced osteomalacia
por: Schober, Hans-Christof, et al.
Publicado: (2017) -
A case report of phosphaturic mesenchymal tumor-induced osteomalacia
por: Wu, Weiqian, et al.
Publicado: (2017) -
Successful treatment of tumor-induced osteomalacia causing by phosphaturic mesenchymal tumor of the foot
por: Liu, Shuzhong, et al.
Publicado: (2019)